⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Official Title: A Phase III, Randomized, Open-Label, Multi-Center, Safety and Efficacy Study to Evaluate Nab-Paclitaxel (Abraxane®) as Maintenance Treatment After Induction With Nab-Paclitaxel Plus Carboplatin in Subjects With Squamous Cell Non-Small Cell Lung Cancer (NSCLC)

Study ID: NCT02027428

Study Description

Brief Summary: Maintenance treatment of advanced stage squamous cell NSCLC. Phase III, randomized, open-label, multi-center study of nab-paclitaxel with best supportive care (BSC) or BSC alone as maintenance treatment after response or stable disease (SD) with nab-paclitaxel plus carboplatin as induction in subjects with stage IIIB/IV squamous cell NSCLC. Subjects who discontinued treatment from the maintenance part for any reason other than withdrawal of consent, lost to follow-up, or death, were entered into a Follow-up period that had a visit 28 days after progression or discontinuation. Those who entered Follow-up without progression continued with follow-up scans according to standard of care (SOC) until documentation of progression of disease. Additionally, subjects were followed for OS by phone approximately every 90 days for a minimum of 18 months, for up to approximately 5 years after the last subject was randomized.

Detailed Description: The sponsor used 15 Sep 2017 as the database cut-off date.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Clearview Cancer Institute Oncology Specialties, P.C, Huntsville, Alabama, United States

Palo Verde Hematology Oncology, Ltd., Glendale, Arizona, United States

Arizona Clinical Research Center, Tucson, Arizona, United States

Genesis Cancer Center, Hot Springs, Arkansas, United States

City of Hope Cancer Center, Duarte, California, United States

Cancer Care Associates of Fresno Medical Group Inc, Fresno, California, United States

University of California San Diego Moores Cancer Center, La Jolla, California, United States

Clinical Trials and Research Associates, Montebello, California, United States

VA Palo Alto Health Care System, Palo Alto, California, United States

Rocky Mountain Cancer Centers, LLP, Denver, Colorado, United States

Yale Cancer Center, New Haven, Connecticut, United States

Lynn Cancer Institute, Boca Raton, Florida, United States

Florida Cancer Specialists, Fort Myers, Florida, United States

Watson Clinic, LLP Center for Cancer Care and Research, Lakeland, Florida, United States

University of Miami Miller School of Medicine Jackson Memorial Hospital, Miami, Florida, United States

Ocala Oncology Center, Ocala, Florida, United States

Orlando Health, Inc, Orlando, Florida, United States

Memorial Cancer Institute West, Pembroke Pines, Florida, United States

Florida Cancer Specialists, Saint Petersburg, Florida, United States

Moffitt Cancer Center, Tampa, Florida, United States

University Cancer and Blood Center, LLC, Athens, Georgia, United States

University of Chicago, Chicago, Illinois, United States

Joliet Oncology-Hematology Associates, Ltd., Joliet, Illinois, United States

Illinois Cancer Specialists, Niles, Illinois, United States

Indiana University Medical Center, Indianapolis, Indiana, United States

Investigative Clinical Research of Indiana, LLC, Indianapolis, Indiana, United States

Kansas University Medical Center, Westwood, Kansas, United States

Cancer Center of Kansas (MAT), Wichita, Kansas, United States

Kentucky Cancer Clinic, Hazard, Kentucky, United States

Norton Healthcare, Louisville, Kentucky, United States

University of Louisville, J.G. Brown Cancer Center, Louisville, Kentucky, United States

Norton Cancer Institute Louisville Oncology, Louisville, Kentucky, United States

LSU Health Sciences Center, New Orleans, Louisiana, United States

Maine Research Associates, Auburn, Maine, United States

Eastern Maine Medical Center, Brewer, Maine, United States

Center For Cancer and Blood Disorders, Bethesda, Maryland, United States

Meritus Medical Center, Hagerstown, Maryland, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Detroit Clinical Research Center, Farmington Hills, Michigan, United States

Western Michigan Cancer Center, Kalamazoo, Michigan, United States

St Joseph Oncology, Saint Joseph, Missouri, United States

Washington University School of Medicine, Saint Louis, Missouri, United States

Mercy Medical Research Institute, Springfield, Missouri, United States

Englewood Hospital and Medical Center, Englewood, New Jersey, United States

Hematology-Oncology Associates of NNJ, P, Morristown, New Jersey, United States

New York Oncology Hematology P.C., Albany, New York, United States

Montefiore Medical Center, Bronx, New York, United States

Montefiore Medical Center Albert Einstein Cancer Center, Bronx, New York, United States

Clinical Research Alliance, Lake Success, New York, United States

NYU Langone Medical Center, Lake Success, New York, United States

Beth Israel Medical Centers, New York, New York, United States

NYU Langone Medical Center, New York, New York, United States

Icahn School of Medicine at Mount Sinai Medical Center, New York, New York, United States

Rochester General Hospital, Rochester, New York, United States

SUNY Upstate Medical University, Syracuse, New York, United States

Carolinas Medical Center, Charlotte, North Carolina, United States

Southeastern Medical Oncology Center, Goldsboro, North Carolina, United States

Moses H. Cone Regional Cancer Center, Greensboro, North Carolina, United States

Hematology and Oncology Associates, Inc., Canton, Ohio, United States

Oncology Hematology Care, Inc., Cincinnati, Ohio, United States

University Hospitals Case Medical Center, Cleveland, Ohio, United States

The Mark H. Zangmeister Center, Columbus, Ohio, United States

Tri-County Hematology and Oncology Associates, Massillon, Ohio, United States

Toledo Community Oncology Program, Toledo, Ohio, United States

Mercy Clinic Oklahoma Communities, Inc., Oklahoma City, Oklahoma, United States

University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

Erie Regional Cancer Center, Erie, Pennsylvania, United States

Abramson Cancer Center, Philadelphia, Pennsylvania, United States

University of Pennsylvania Health Systems, Philadelphia, Pennsylvania, United States

Allegheny Singer Research Institute, Pittsburgh, Pennsylvania, United States

University of Pittsburgh Medical Center - Cancer Pavilion, Pittsburgh, Pennsylvania, United States

Greenville Hospital System, Greenville, South Carolina, United States

Chattanooga Oncology Hematology Care, Chattanooga, Tennessee, United States

Associates in Oncology and Hematology, Chattanooga, Tennessee, United States

Thompson Cancer Survival Center, Knoxville, Tennessee, United States

Sarah Cannon Cancer Center, Nashville, Tennessee, United States

Vanderbilt University Medical Center, Nashville, Tennessee, United States

TX Onc, PA- Beaumont, Beaumont, Texas, United States

Brooke Army Medical Center Francis Street Medical Center, Fort Sam Houston, Texas, United States

Center for Cancer and Blood Disorders, Fort Worth, Texas, United States

Houston Methodist Cancer Center, Houston, Texas, United States

UT Health Oncology, Houston, Texas, United States

Millenium Oncology, Houston, Texas, United States

TX Onc Tyler Cancer Center, Tyler, Texas, United States

Columbia Basin Hematology and Oncology, Kennewick, Washington, United States

Swedish Cancer Institute, Seattle, Washington, United States

St Mary's Medical Center, Huntington, West Virginia, United States

West Virginia University, Berkeley Medical Center, Cancer and Infusion Center, Martinsburg, West Virginia, United States

West Virginia University, Berkeley Medical Center, Cancer and Infusion Center, Morgantown, West Virginia, United States

Medical College of Wisconsin, Milwaukee, Wisconsin, United States

St. Antonius Hospital, Eschweiler, , Germany

Asklepios Fachkliniken Muenchen Gauting, Gauting, , Germany

Diakoniekrankenhaus Halle, Halle (Saale), , Germany

Universitatsklinikum Halle Saale, Halle, , Germany

Thorax Klinik, Heidelberg, , Germany

Universitat Des Saarlandes, Homburg, , Germany

Kliniken der Stadt Koln gGmbH - Krankenhaus Merheim, Koln, , Germany

Klinik Loewenstein gGmbH, Loewenstein, , Germany

Lungenklinik Lostau gGmbH, Lostau, , Germany

Universitatsklinikum Ulm, Ulm, , Germany

Azienda Ospedaliera di Rilievo Nazionale e di Alta Specialita San Giuseppe Moscati, Avellino, , Italy

Azienda Ospedaliero Universitaria Di Bologna - Policlinico S.Orsola Malpighi, Bologna, , Italy

Azienda Ospedaliera Istituti Ospitalieri di Cremona, Cremona, , Italy

Istituto Nazionale Per La Ricerca Sul Cancro, Genova, , Italy

Istituto Europeo di Oncologia, Milano, , Italy

Azienda Ospedaliera San Gerardo, Monza, , Italy

Istituto Nazionale Tumori Regina Elena di Roma, Roma, , Italy

Ospedale San Vincenzo Taormina, Taormina, , Italy

Intituto Catalán de Oncología de Girona, Girona, , Spain

Hospital Clinico San Carlos, Madrid, , Spain

Hospital Universitario 12 de Octubre, Madrid, , Spain

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, , Spain

Hospital Universitario Central de Asturias, Oviedo, , Spain

Hospital General Universitario de Valencia, Valencia, , Spain

Hospital Universitari i Politecnic La Fe de Valencia, Valencia, , Spain

Hospital Universitario Lozano Blesa, Zaragoza, , Spain

Churchhill Hospital, Oxford, , United Kingdom

Royal Marsden Hospital, Sutton, , United Kingdom

Contact Details

Name: Teng Jin Ong, MD

Affiliation: Celgene

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: